Amgen: Large biotechnology company focused on oncology, inflammation, and rare diseases.
| Venues | Issuers | Symbol | Mark | Volume 24h | Liquidity | Vol % | Contract |
|---|---|---|---|---|---|---|---|
| AMGN | 417.35 | $208.98 | — | 100.0% | 0x1c5f…2d82 |
AMGN▲AMGN listed on HTX
21dAMGN▲AMGN listed on WEEX
23dAMGN▼FTC conducts antitrust review of Amgen's patent application acquisition deal
2026-08-21AMGN▲Amgen raises FY adjusted EPS guidance to $22.30-$23.50 from $21.70-$23.10
×22026-08-04AMGN▲Amgen Q2 revenue $10.05B beats $9.44B est, EPS $6.29 vs $5.62
2026-08-04